Turkish Antitrust Authorities Investigate Teva for Alleged Patent System Manipulation and Rival Drug Disparagement
Source Summary
Turkish antitrust authorities are investigating Teva Pharmaceutical for allegedly manipulating the patent system and disparaging rival drugs. The investigation focuses on competitive practices that may violate antitrust regulations.
Why it matters
Antitrust investigations can result in significant fines and operational restrictions for pharmaceutical companies, affecting their competitive position and financial performance.
